Intradetrusor botulinum toxin as the first-line treatment for neurogenic detrusor overactivity: Cons-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intradetrusor botulinum toxin as the first-line treatment for neurogenic detrusor overactivity: Cons

Published:2023-03 Issue:4 Volume:33 Page:176-177
ISSN:1166-7087
Container-title:Progrès en Urologie
language:en
Short-container-title:Progrès en Urologie

Author:

Del Popolo G.,Gemma L.

Publisher

Elsevier BV

Subject

Urology

Reference5 articles.

1. Botulinum toxin in urology: a review of clinical potential in the treatment of urologic and sexual conditions;Chung;Expert Opin Biol Ther,2015

2. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial;Cruz;Eur Urol,2011

3. EAU Guidelines Office, Arnhem, The Netherlands. http://uroweb.org/guidelines/compilations-of-all-guidelines/.

4. The use of oxybutynin in patients treated by means of botulinum neurotoxin A for neurogenic detrusor overactivity: an observational study;Finazzi-Agrò;Spinal Cord.,2013

5. Neurogenic bladder in patients with paraplegia: a two-center study of the real-life experience of the patients’ journey;Blé;World J Urol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP